Use of memantine (NAMENDA) to treat autism, compulsivity, and impulsivity

Details for Australian Patent Application No. 2005286943 (hide)

Owner Mount Sinai School of Medicine

Inventors Hollander, Eric

Agent Wrays

Pub. Number AU-A-2005286943

PCT Pub. Number WO2006/034187

Priority 60/611,534 20.09.04 US

Filing date 19 September 2005

Wipo publication date 30 March 2006

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/034187 Priority application(s): WO2006/034187

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286944-Compositions and methods for obesity screening using polymorphisms in NPY2R

2005286941-Method for dynamic rate adaptation based on selective passive network monitoring